Profiles

Keywords
Last Name
Institution

Meenakshi Jolly

Concepts (285)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lupus Erythematosus, Systemic
74
2021
190
24.330
Why?
Quality of Life
38
2021
636
8.450
Why?
Health Status
11
2018
252
2.880
Why?
Severity of Illness Index
28
2020
1233
2.730
Why?
Psychometrics
15
2020
286
2.670
Why?
Rheumatology
6
2019
80
2.320
Why?
Body Image
6
2017
38
2.280
Why?
Adult
54
2021
9760
2.080
Why?
Self Report
7
2017
217
1.890
Why?
Female
65
2021
18107
1.850
Why?
Middle Aged
48
2021
11256
1.820
Why?
Humans
83
2021
30741
1.730
Why?
Patient Outcome Assessment
3
2015
49
1.660
Why?
Reproducibility of Results
19
2020
875
1.660
Why?
Hydroxychloroquine
3
2021
8
1.620
Why?
Lupus Erythematosus, Discoid
3
2021
11
1.530
Why?
Cross-Cultural Comparison
8
2020
40
1.510
Why?
Antirheumatic Agents
3
2021
95
1.470
Why?
Male
48
2021
17552
1.420
Why?
Pain
7
2020
318
1.270
Why?
Cross-Sectional Studies
14
2021
957
1.210
Why?
Fatigue
4
2020
67
1.120
Why?
Lupus Erythematosus, Cutaneous
2
2014
6
1.090
Why?
Health Status Indicators
3
2014
82
1.050
Why?
Pneumococcal Infections
1
2021
9
0.950
Why?
Interferon-alpha
7
2014
82
0.930
Why?
Sickness Impact Profile
4
2014
21
0.880
Why?
Antibodies, Antinuclear
5
2018
21
0.870
Why?
Depression
4
2020
502
0.870
Why?
Pain Measurement
5
2019
475
0.850
Why?
Outpatient Clinics, Hospital
1
2018
14
0.760
Why?
Lupus Nephritis
2
2017
33
0.760
Why?
Delivery of Health Care, Integrated
1
2018
30
0.740
Why?
Quality Indicators, Health Care
1
2018
44
0.730
Why?
Academic Medical Centers
1
2019
162
0.700
Why?
Cost of Illness
2
2015
65
0.700
Why?
Factor Analysis, Statistical
7
2020
75
0.690
Why?
Unnecessary Procedures
1
2017
30
0.670
Why?
Physicians
3
2015
112
0.660
Why?
Young Adult
12
2020
2249
0.660
Why?
Culture
2
2013
30
0.650
Why?
Tattooing
2
2007
2
0.650
Why?
Canada
4
2018
56
0.630
Why?
Biological Products
1
2016
35
0.620
Why?
Adolescent
11
2020
2627
0.610
Why?
Linear Models
6
2018
277
0.580
Why?
Immunoglobulin lambda-Chains
1
2014
4
0.560
Why?
Immunoglobulin kappa-Chains
1
2014
5
0.560
Why?
Interleukin-10
1
2014
42
0.550
Why?
Language
5
2020
78
0.540
Why?
Autoantibodies
8
2013
116
0.540
Why?
Interleukin-6
1
2014
120
0.530
Why?
Arthritis, Rheumatoid
4
2019
377
0.530
Why?
Posterior Leukoencephalopathy Syndrome
1
2013
16
0.530
Why?
United States
7
2018
2467
0.520
Why?
Teaching
2
2019
62
0.520
Why?
Caregivers
1
2015
147
0.510
Why?
Cultural Characteristics
1
2013
25
0.510
Why?
Patient Education as Topic
1
2014
192
0.510
Why?
Dermatology
1
2012
8
0.500
Why?
Treatment Outcome
10
2018
3850
0.500
Why?
Diagnostic Self Evaluation
1
2012
16
0.500
Why?
Hospitals, County
1
2012
4
0.500
Why?
Hospitals, University
1
2012
45
0.490
Why?
Body Dysmorphic Disorders
1
2011
4
0.480
Why?
Adaptation, Psychological
5
2016
178
0.480
Why?
Longitudinal Studies
6
2020
1432
0.470
Why?
Emotions
3
2017
96
0.460
Why?
Immunoglobulin Light Chains
1
2011
9
0.460
Why?
Polymorphism, Single Nucleotide
8
2017
331
0.460
Why?
Quality of Health Care
1
2012
135
0.440
Why?
Benchmarking
1
2010
29
0.430
Why?
Demography
1
2010
82
0.410
Why?
Income
1
2010
71
0.400
Why?
Aged
10
2021
10156
0.400
Why?
Genetic Predisposition to Disease
6
2018
473
0.400
Why?
Activities of Daily Living
2
2012
472
0.390
Why?
Clinical Trials as Topic
4
2016
386
0.380
Why?
Case-Control Studies
6
2014
694
0.360
Why?
Predictive Value of Tests
4
2017
631
0.360
Why?
Randomized Controlled Trials as Topic
3
2016
361
0.360
Why?
Stress, Psychological
3
2020
278
0.360
Why?
Paracentesis
1
2007
4
0.350
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2007
2
0.340
Why?
Suction
1
2007
46
0.340
Why?
Genital Diseases, Female
1
2006
11
0.330
Why?
Reference Values
3
2014
258
0.330
Why?
Hyperuricemia
1
2006
5
0.320
Why?
Chronic Disease
2
2005
542
0.310
Why?
Takayasu Arteritis
1
2005
1
0.310
Why?
Uveitis
1
2005
8
0.310
Why?
Vasculitis
1
2005
35
0.300
Why?
Chicago
2
2018
945
0.290
Why?
Leukoencephalopathy, Progressive Multifocal
1
2007
121
0.290
Why?
Pre-Eclampsia
1
2004
8
0.290
Why?
Chlamydia trachomatis
1
2004
16
0.280
Why?
Chlamydia Infections
1
2004
8
0.280
Why?
Tumor Necrosis Factor-alpha
1
2005
228
0.280
Why?
Pregnancy Complications
1
2004
57
0.280
Why?
African Americans
6
2015
780
0.270
Why?
Prognosis
3
2014
1045
0.270
Why?
Heart Diseases
1
2005
102
0.270
Why?
Antibodies, Monoclonal
1
2005
311
0.270
Why?
Translations
2
2013
16
0.270
Why?
Depressive Disorder
2
2018
213
0.260
Why?
Diagnosis, Differential
3
2013
469
0.250
Why?
Comorbidity
3
2013
562
0.240
Why?
Vaccination
1
2021
42
0.230
Why?
Cardiovascular Diseases
1
2006
391
0.230
Why?
Sex Factors
2
2018
535
0.230
Why?
Immunocompromised Host
1
2021
56
0.230
Why?
Prospective Studies
3
2020
1891
0.220
Why?
Regression Analysis
3
2020
323
0.210
Why?
Autoimmunity
2
2010
23
0.210
Why?
Health Surveys
2
2017
101
0.210
Why?
Azacitidine
1
2019
13
0.200
Why?
Cohort Studies
6
2017
1959
0.200
Why?
Multivariate Analysis
2
2018
391
0.200
Why?
Databases, Factual
1
2021
372
0.200
Why?
Asia
1
2018
11
0.190
Why?
Appointments and Schedules
1
2018
15
0.190
Why?
Europe
1
2018
86
0.190
Why?
Faculty, Medical
1
2019
30
0.190
Why?
Morbidity
1
2018
71
0.190
Why?
Mentors
1
2019
38
0.190
Why?
Patient Acuity
1
2018
10
0.190
Why?
Sex Distribution
1
2018
91
0.190
Why?
Age Factors
3
2016
941
0.190
Why?
Enzyme Inhibitors
1
2019
160
0.190
Why?
Workload
1
2018
39
0.190
Why?
Phenotype
4
2012
368
0.180
Why?
Arthritis, Experimental
1
2019
139
0.180
Why?
Biomedical Research
1
2019
85
0.180
Why?
Interferon Type I
2
2017
20
0.180
Why?
Pilot Projects
2
2020
440
0.180
Why?
DNA Methylation
1
2019
165
0.170
Why?
Genome-Wide Association Study
4
2012
308
0.170
Why?
Philippines
2
2017
3
0.170
Why?
Blood Sedimentation
1
2017
65
0.170
Why?
Psychiatric Status Rating Scales
1
2018
386
0.170
Why?
Health Care Surveys
1
2017
76
0.170
Why?
Risk Assessment
2
2014
804
0.170
Why?
Toll-Like Receptors
1
2017
29
0.170
Why?
Retrospective Studies
2
2018
3456
0.170
Why?
Illinois
1
2017
268
0.160
Why?
Health Status Disparities
1
2017
68
0.160
Why?
France
1
2016
39
0.160
Why?
Mental Health
1
2017
114
0.160
Why?
Macrophages
1
2017
114
0.160
Why?
Socioeconomic Factors
3
2016
362
0.160
Why?
Arthralgia
2
2008
119
0.150
Why?
Sleep Initiation and Maintenance Disorders
1
2017
116
0.150
Why?
Hong Kong
1
2015
3
0.150
Why?
Interferon Regulatory Factor-7
2
2017
4
0.150
Why?
Software
1
2015
73
0.150
Why?
Self Concept
2
2012
53
0.150
Why?
Cosmetic Techniques
1
2014
4
0.150
Why?
Critical Pathways
1
2014
23
0.140
Why?
Professional-Patient Relations
1
2015
32
0.140
Why?
Magnetic Resonance Imaging
2
2013
1244
0.140
Why?
Time Factors
2
2017
1911
0.140
Why?
Focus Groups
1
2014
91
0.140
Why?
Double-Blind Method
1
2016
550
0.140
Why?
Chi-Square Distribution
1
2014
181
0.140
Why?
Goals
1
2014
49
0.140
Why?
Dose-Response Relationship, Drug
1
2015
527
0.140
Why?
Interferon Regulatory Factors
1
2013
2
0.140
Why?
Turkey
1
2013
5
0.130
Why?
Sleep
1
2017
340
0.130
Why?
Genetic Variation
2
2011
117
0.130
Why?
Promoter Regions, Genetic
2
2011
106
0.130
Why?
Latin America
1
2013
7
0.130
Why?
Combined Modality Therapy
1
2014
473
0.130
Why?
Matched-Pair Analysis
1
2012
24
0.120
Why?
Multiple Sclerosis
1
2013
88
0.120
Why?
Self-Assessment
1
2012
28
0.120
Why?
Feedback
1
2012
26
0.120
Why?
Osteopontin
1
2011
4
0.120
Why?
Ubiquitin-Conjugating Enzymes
1
2011
6
0.120
Why?
Disease Management
1
2013
149
0.120
Why?
DEAD-box RNA Helicases
1
2011
5
0.120
Why?
Quality Improvement
1
2013
169
0.120
Why?
Gene Expression Profiling
1
2012
183
0.110
Why?
Complementary Therapies
1
2011
15
0.110
Why?
Sensitivity and Specificity
1
2013
594
0.110
Why?
DNA
4
2013
140
0.110
Why?
Genetic Association Studies
1
2011
90
0.110
Why?
Alleles
4
2011
230
0.110
Why?
Class III Phosphatidylinositol 3-Kinases
1
2010
1
0.110
Why?
Models, Genetic
1
2010
44
0.110
Why?
Aged, 80 and over
2
2019
5172
0.110
Why?
Epitopes
1
2010
91
0.110
Why?
Phosphatidylinositol 3-Kinases
1
2010
51
0.100
Why?
Intracellular Signaling Peptides and Proteins
1
2010
65
0.100
Why?
Self-Examination
1
2009
3
0.100
Why?
Nuclear Proteins
1
2010
96
0.100
Why?
Social Environment
1
2010
93
0.100
Why?
California
3
2017
34
0.100
Why?
Disease Models, Animal
2
2019
831
0.100
Why?
Follow-Up Studies
1
2014
2046
0.100
Why?
Educational Status
1
2010
285
0.090
Why?
Cytokines
1
2010
348
0.090
Why?
Analgesics, Non-Narcotic
1
2008
18
0.090
Why?
Prevalence
2
2011
546
0.090
Why?
Therapeutic Irrigation
1
2007
66
0.080
Why?
Animals
3
2019
5221
0.080
Why?
Fatal Outcome
1
2007
76
0.080
Why?
Patient Satisfaction
1
2010
308
0.080
Why?
Education, Medical, Undergraduate
1
2007
36
0.080
Why?
Vulva
1
2006
3
0.080
Why?
Injections, Intra-Articular
1
2007
77
0.080
Why?
Data Collection
1
2007
118
0.080
Why?
Joints
1
2007
101
0.080
Why?
Skin Diseases
1
2006
37
0.080
Why?
Cognition
1
2014
1141
0.080
Why?
Hepatitis B
1
2005
20
0.080
Why?
Probability
1
2005
107
0.080
Why?
Disability Evaluation
2
2020
330
0.080
Why?
Autoimmune Diseases
2
2019
64
0.070
Why?
Pregnancy Outcome
1
2004
20
0.070
Why?
Genotype
3
2011
447
0.070
Why?
Sulfasalazine
1
2004
4
0.070
Why?
Lactones
1
2004
14
0.070
Why?
Sulfones
1
2004
27
0.070
Why?
Doxycycline
1
2004
23
0.070
Why?
Internship and Residency
1
2007
187
0.070
Why?
Methotrexate
1
2004
48
0.070
Why?
Myocardial Infarction
1
2005
191
0.070
Why?
Drug Therapy, Combination
1
2004
266
0.070
Why?
Synovial Fluid
1
2004
137
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2004
109
0.070
Why?
Osteoarthritis, Knee
1
2008
362
0.060
Why?
Pregnancy
1
2004
452
0.060
Why?
Mice
2
2019
1843
0.060
Why?
Hypertension
1
2004
272
0.060
Why?
Ribonucleoproteins
2
2011
4
0.060
Why?
Cell Line
2
2012
354
0.060
Why?
Egypt
1
2020
3
0.050
Why?
Anti-Bacterial Agents
1
2004
403
0.050
Why?
Polymorphism, Genetic
2
2011
96
0.050
Why?
Chromatin Immunoprecipitation
1
2019
28
0.050
Why?
Gene Silencing
1
2019
26
0.050
Why?
Anxiety
1
2020
159
0.050
Why?
Flow Cytometry
1
2019
224
0.050
Why?
B-Lymphocytes
1
2019
95
0.050
Why?
Complement C1q
1
2018
3
0.050
Why?
Malaria
1
2018
5
0.050
Why?
Immunoglobulin M
1
2018
22
0.050
Why?
Glucocorticoids
1
2018
77
0.040
Why?
Immunoglobulin G
1
2018
137
0.040
Why?
Georgia
1
2017
16
0.040
Why?
Southeastern United States
1
2017
15
0.040
Why?
Mice, Inbred MRL lpr
1
2017
3
0.040
Why?
Interferon Regulatory Factor-3
1
2017
3
0.040
Why?
Japan
1
2016
14
0.040
Why?
Australia
1
2016
48
0.040
Why?
Social Class
1
2017
72
0.040
Why?
Proto-Oncogene Proteins c-akt
1
2017
72
0.040
Why?
Registries
1
2017
203
0.040
Why?
Child
1
2020
1547
0.040
Why?
Disabled Persons
1
2016
110
0.040
Why?
Risk Factors
2
2011
2611
0.030
Why?
3' Untranslated Regions
1
2011
4
0.030
Why?
Anemia, Hemolytic
1
2011
3
0.030
Why?
Autoantigens
1
2011
38
0.030
Why?
Thrombocytopenia
1
2011
31
0.030
Why?
Mexican Americans
1
2011
28
0.030
Why?
Receptors, Lysophosphatidic Acid
1
2010
1
0.030
Why?
Databases, Genetic
1
2010
12
0.030
Why?
Principal Component Analysis
1
2010
27
0.030
Why?
Aminopeptidases
1
2010
7
0.030
Why?
Protein Structure, Quaternary
1
2010
8
0.030
Why?
Antibody Specificity
1
2010
58
0.030
Why?
Immunoprecipitation
1
2010
27
0.030
Why?
Immunoblotting
1
2010
66
0.030
Why?
Transfection
1
2010
153
0.030
Why?
Gene Frequency
1
2010
86
0.030
Why?
Interferon-gamma
1
2010
120
0.030
Why?
Genetic Loci
1
2010
68
0.030
Why?
Polymerase Chain Reaction
1
2010
209
0.030
Why?
DNA-Binding Proteins
1
2010
258
0.020
Why?
Gene Expression Regulation
1
2010
348
0.020
Why?
Signal Transduction
1
2011
582
0.020
Why?
Algorithms
1
2010
421
0.020
Why?
Knee Joint
1
2008
743
0.010
Why?
Jolly's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description